Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
ID: 351337Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $125K

Eligible Applicants

Others

Funding Category

Income Security and Social Services

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/351337

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-318.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)." This initiative aims to support exploratory and developmental research focused on the creation and evaluation of innovative mobile health (mHealth) interventions tailored for low- and middle-income countries (LMICs), emphasizing partnerships between U.S. institutions and LMIC entities. The program seeks to enhance health outcomes and research capacity in these regions through a two-phase funding structure, with an award ceiling of $125,000 and a total project period of up to five years. Interested applicants can find more information and guidelines at the NIH grants website and should submit their proposals by March 20, 2026, for consideration.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-318-Full-Announcement.html
    PAR-23-318.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a Notice of Funding Opportunity (NOFO) titled "Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)." This funding initiative seeks to foster exploratory research focusing on the development and effectiveness of mobile health (mHealth) technologies tailored for low- and middle-income countries (LMICs). Projects should leverage innovative technologies to improve health outcomes and bolster mHealth capacities in these regions, with a two-phase funding structure: R21 for initial feasibility studies and R33 for expanded validation research. Key considerations include partnerships between U.S. and LMIC institutions, a focus on user-centered design, and strategies for addressing specific health concerns prevalent in LMICs. Eligibility encompasses a wide range of organizations, with priority given to applications that integrate diverse research teams, especially those including underrepresented individuals. The total project period can extend up to five years, and grant applicants must follow strict NIH guidelines for submission and review, highlighting the critical role of mHealth interventions in enhancing healthcare in resource-limited settings.
    Similar Opportunities
    Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)" aimed at promoting exploratory research on mobile health (mHealth) technologies in low- and middle-income countries (LMICs). This initiative seeks to develop, validate, and assess innovative mHealth interventions that utilize emerging technologies to improve health outcomes in LMICs, with a focus on fostering multidisciplinary research and building research capacity in these regions. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with a requirement for partnerships between U.S. institutions and LMIC researchers. The funding amount can reach up to $125,000, with applications due by March 20, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-318.html.
    HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for research initiatives focused on HIV-associated non-communicable diseases (NCDs) at low- and middle-income country (LMIC) institutions through the R21 Clinical Trial Optional grant. This program aims to support locally relevant research that explores the relationship between HIV infection and the development of NCDs, enhance research capacity, and foster collaborative networks among researchers in LMICs and the U.S. The grant provides funding up to $275,000 over a two-year period, with a submission deadline of December 8, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for investigator-initiated clinical trials focused on complementary and integrative health interventions delivered remotely or via mobile health (mHealth) technologies. Applicants are required to design fully powered clinical trials that do not involve in-person contact between research staff and participants, providing preliminary data on the feasibility, safety, and potential clinical benefits of their proposed interventions. This initiative aligns with the NIH's commitment to addressing public health challenges and expanding access to integrative health approaches, particularly in areas of high research priority identified by the National Center for Complementary and Integrative Health (NCCIH). Interested applicants should note that the submission period opens on January 20, 2025, and must include a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the funding opportunity titled "Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth." This initiative encourages the submission of proposals for fully remotely conducted clinical trials aimed at assessing the efficacy of complementary and integrative health interventions, particularly in areas designated as high research priorities by the National Center for Complementary and Integrative Health (NCCIH). The trials must involve no in-person contact between research staff and participants, utilizing mobile health technologies, and applicants are required to provide preliminary data demonstrating the feasibility and safety of their proposed approaches, along with a Plan for Enhancing Diverse Perspectives (PEDP) that will be evaluated during the review process. The application period opens on January 20, 2024, with a submission deadline of February 20, 2026. Interested applicants can find more information and guidance at the NIH website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R61/R33 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the implementation research grant titled "Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R61/R33 Clinical Trial Required)." This funding opportunity aims to improve integrated care for individuals with multimorbidity of non-communicable diseases (NCDs) in low- and middle-income countries (LMICs) and American Indian/Alaska Native (AI/AN) populations in the U.S., emphasizing evidence-based interventions that are tailored to local contexts. The grant utilizes a two-phase R61/R33 mechanism, allowing for an initial one-year planning phase followed by potential implementation support for up to four additional years, with a total funding ceiling of $500,000. Interested applicants should note that the application process opens on January 7, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional)." This initiative aims to support implementation research that develops, optimizes, and tests innovative strategies for integrating mental health care into both healthcare systems and community settings in low- and middle-income countries (LMICs). The focus is on enhancing accessibility, quality, and sustainability of mental health services while fostering partnerships between institutions in LMICs and high-income countries. Interested applicants can find more information and guidelines at the NIH grants website, with applications due by January 7, 2028. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) to support innovative research aimed at addressing minority health and health disparities in the United States. This grant invites applications for short-term exploratory projects that can either pioneer new advancements or build upon previous findings, with a maximum funding amount of $275,000 available for a two-year project period, limiting annual requests to $200,000. The program emphasizes the importance of diverse representation among applicants and encourages partnerships with relevant stakeholders, focusing on NIH-designated health disparity populations through various research methodologies. Interested applicants can find more information and submission guidelines at the provided link, with the application deadline set for May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Funding Opportunity Announcement: Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at soliciting applications for research focused on developing biomedical technologies that address health disparities. This initiative seeks to support projects that create effective, affordable, and socially acceptable technologies to improve healthcare access and outcomes for underserved populations. The estimated total program funding for this opportunity is $1,200,000, with an expected two awards to be made, and the application process is anticipated to open in late 2025. Interested applicants can reach out to Nichole Daringer at nichole.daringer@nih.gov or call 301-451-4774 for further information.
    Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Small Business Technology Transfer (STTR) program, aimed at developing technologies to improve minority health and eliminate health disparities. Eligible applicants, specifically United States small business concerns (SBCs), are invited to submit grant applications for the R41/R42 program, which may include clinical trials, focusing on innovative solutions that are effective, affordable, and culturally acceptable for underserved populations. This initiative emphasizes the importance of addressing health inequities through technology, including disease self-management tools and mobile health solutions, with applications due by December 9, 2026. For further details, applicants can refer to the full announcement at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting proposals for the R21 Exploratory/Developmental Research Grant under the funding opportunity titled "Innovations to Optimize HIV Prevention and Care Continuum Outcomes." This initiative aims to support innovative research that enhances HIV prevention and care strategies by exploring behavioral and social science approaches, new intervention methods, and implementation science, particularly addressing gaps in engagement, adherence, and retention in healthcare services. The grant, with a funding ceiling of $275,000 over two years, emphasizes collaboration with community organizations and the inclusion of diverse populations, aligning with national and global health objectives. Interested applicants can submit their proposals until January 9, 2026, and should direct inquiries to NIH Grants Information at grantsinfo@nih.gov.